Evidence map›Paper›PMID 39684475›Full record

ArticleInternational journal of molecular sciences2024

Association of Sympathovagal Imbalance with Increased Inflammation and Impaired Adaptive Immunity in Bladder Cancer Patients.

Iveta Mikolaskova, Milan Zvarik, Kinga Szaboova, Elena Tibenska, Vladimira Durmanova, Magda Suchankova, Boris Kollarik, Patrik Hesko, Patrik Palacka, Maria Bucova and 1 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Association ofInternational journal of molecular sciences · 2026
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Iveta MikolaskovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Odborarske namestie 14, 811 08 Bratislava, Slovakia.ORCID 0000-0003-4443-9069
Milan ZvarikDepartment of Nuclear Physics and Biophysics, Faculty of Mathematics, Physics and Computer Science, Comenius University in Bratislava, Mlynska dolina F1, 842 48 Bratislava, Slovakia.ORCID 0000-0002-0165-6066
Kinga SzaboovaMedirex, s.r.o., Galvaniho 17/C, 820 16 Bratislava, Slovakia.
Elena TibenskaMedirex, s.r.o., Galvaniho 17/C, 820 16 Bratislava, Slovakia.
Vladimira DurmanovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Odborarske namestie 14, 811 08 Bratislava, Slovakia.
Magda SuchankovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Odborarske namestie 14, 811 08 Bratislava, Slovakia.
Boris KollarikDepartment of Urology, Saint Cyril and Methodius Hospital, Antolska 11, 851 07 Bratislava, Slovakia.
Patrik HeskoDepartment of Urology, Saint Cyril and Methodius Hospital, Antolska 11, 851 07 Bratislava, Slovakia.
Patrik Palacka2nd Department of Oncology, Faculty of Medicine, Comenius University in Bratislava, Kolarska 12, 812 50 Bratislava, Slovakia.
Maria BucovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Odborarske namestie 14, 811 08 Bratislava, Slovakia.
Luba HunakovaInstitute of Immunology, Faculty of Medicine, Comenius University in Bratislava, Odborarske namestie 14, 811 08 Bratislava, Slovakia.ORCID 0000-0003-2159-0807

Funding

The Scientific Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic and Slovak Academy of Sciences VEGA 1/0090/22the Slovak Research and Development Agency APVV-22-0231
6 · The paper itself

Abstract

Stress responses can impact bladder cancer (BC) outcomes via immune-inflammatory pathway modulation. This study explores heart rate variability (HRV) associations with serum immune-inflammatory biomarkers, blood count inflammatory markers, and psychosocial self-report measures in patients versus healthy controls. The TREM-1 and TREM-2 expressions on peripheral blood monocytes were analysed via flow cytometry; serum inflammatory biomarkers by ELISA; HRV (5-min ECG) pre-tumour resection; blood counts by haematology analyser; and psychosocial factors by validated questionnaires. Patients exhibited altered immune-inflammatory profiles with increased TREM-1/TREM-2, sTREM-1, sTREM-1/sTREM-2 ratio, BDNF, MCP-1, and NLR, and reduced IFN-γ, IL-10, LMR, and PMR. HRV analysis indicated sympathetic dominance (SNS, Stress indices, ACmod) and reduced parasympathetic modulation (PNS index, SDNN, RMSSD, 2UV%, DCmod, SD1). Sympathetic HRV indices correlated positively with sTREM-1, sTREM-1/sTREM-2 ratio, fractalkine, and inflammatory markers (SII, NLR, PLR) and negatively with parasympathetic HRV indices-correlations absent in controls. Only in patients, reduced physical function and social support, and higher anxiety, depression, and fatigue, associated positively with sympathetic HRV indices and inflammatory markers. This study links immune-inflammatory markers, HRV parameters, and psychosocial factors in BC, suggesting that immune and autonomic variations may relate to unfavourable outcomes. Incorporating these assessments could help tailor more personalised treatment strategies for BC patients.

Indexed as

Adaptive ImmunityInflammationUrinary Bladder NeoplasmsAgedBiomarkersFemaleHeart RateHumansMaleMembrane GlycoproteinsMiddle AgedReceptors, ImmunologicSympathetic Nervous SystemTriggering Receptor Expressed on Myeloid Cells-1Vagus NerveBiomarkersMembrane GlycoproteinsReceptors, ImmunologicTREM2 protein, humanTriggering Receptor Expressed on Myeloid Cells-1autonomic nervous systembladder cancerheart-rate variabilityimmune–inflammatory markersstress

Identifiers

PMID39684475
PMCPMC11641687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.